Seropram



Indications and Reactions:

Role Indications Reactions
Primary
Depression 100.0%
Musculoskeletal Pain 50.0%
Sleep Disorder 50.0%
Secondary
Drug Use For Unknown Indication 35.3%
Depression 16.8%
Product Used For Unknown Indication 8.5%
Anxiety 5.2%
Hypertension 3.9%
Drug Exposure During Pregnancy 3.3%
Osteomyelitis 3.0%
Ill-defined Disorder 2.8%
Infection Prophylaxis 2.2%
Asthma 1.9%
Essential Hypertension 1.9%
Insomnia 1.9%
Major Depression 1.9%
Acne 1.7%
Diabetes Mellitus Non-insulin-dependent 1.7%
Hepatitis C 1.7%
Hiv Infection 1.7%
Pain 1.7%
Parkinson's Disease 1.7%
Arrhythmia 1.4%
Hyponatraemia 10.8%
Suicide Attempt 10.8%
Drug Exposure During Pregnancy 7.2%
Hepatitis Toxic 7.2%
Premature Baby 7.2%
Agranulocytosis 4.8%
Somnolence 4.8%
Haematoma 3.6%
Intravascular Haemolysis 3.6%
Pyrexia 3.6%
Respiratory Failure 3.6%
Resting Tremor 3.6%
Thrombocytopenia 3.6%
Tremor 3.6%
Urinary Incontinence 3.6%
Urinary Retention 3.6%
Vertigo 3.6%
Vomiting 3.6%
White Blood Cell Count Decreased 3.6%
White Blood Cell Count Increased 3.6%
Concomitant
Drug Use For Unknown Indication 34.8%
Product Used For Unknown Indication 13.8%
Depression 11.8%
Hypertension 6.1%
Hiv Infection 4.7%
Pain 3.3%
Anxiety 3.3%
Hepatitis C 2.3%
Bipolar Disorder 2.1%
Breast Cancer 2.1%
Infection 1.8%
Prophylaxis 1.8%
Metastases To Bone 1.8%
Asthma 1.7%
Osteoporosis 1.6%
Multiple Sclerosis 1.5%
Parkinson's Disease 1.5%
Atrial Fibrillation 1.4%
Psoriatic Arthropathy 1.4%
Back Pain 1.1%
Renal Failure Acute 12.2%
Thrombocytopenia 12.2%
Vomiting 12.2%
Renal Failure 7.5%
Weight Decreased 6.8%
Sepsis 6.1%
Tooth Extraction 4.8%
Toothache 4.1%
Anaemia 3.4%
General Physical Health Deterioration 3.4%
Myocardial Infarction 3.4%
Septic Shock 3.4%
Acute Myeloid Leukaemia 2.7%
Agranulocytosis 2.7%
Malaise 2.7%
Neutropenia 2.7%
Syncope 2.7%
Ventricular Tachycardia 2.7%
Bone Disorder 2.0%
Cerebral Haemorrhage 2.0%
Interacting
Depression 17.8%
Rheumatoid Arthritis 13.3%
Cirrhosis Alcoholic 6.7%
Ill-defined Disorder 6.7%
Pain 6.7%
Stent Related Infection 6.7%
Anxiety Disorder 4.4%
Dementia Alzheimer's Type 4.4%
Embolism 4.4%
Parkinson's Disease 4.4%
Thrombosis 4.4%
Cachexia 2.2%
Diabetes Mellitus Non-insulin-dependent 2.2%
Drug Use For Unknown Indication 2.2%
Enterococcal Infection 2.2%
Epilepsy 2.2%
Hepatic Cirrhosis 2.2%
Hypertension 2.2%
Lung Disorder 2.2%
Neuralgia 2.2%
Serotonin Syndrome 18.8%
Shock 12.5%
Vomiting 12.5%
Drug Interaction 6.3%
Epistaxis 6.3%
Fractured Sacrum 6.3%
Hepatic Encephalopathy 6.3%
Intentional Overdose 6.3%
Memory Impairment 6.3%
Subcutaneous Haematoma 6.3%
Suicide Attempt 6.3%
Weight Decreased 6.3%